Phase I/II trial of cisplatin and doxorubicin with SDZ PSC 833 in patients with refractory ovarian cancer. - Baekelandt,M.; Covelli,A.; Trope,C.; Kristensen,G. (Proc Am Soc Clin Oncol, 1997)